ClinicalTrials.Veeva

Menu

Treatment of Plantar Fasciitis With Injection af Platelet-rich Plasma Into the Origin of the Plantar Fascia

K

Kolding Sygehus

Status and phase

Unknown
Phase 4

Conditions

Plantar Fasciitis

Treatments

Biological: Plasma
Biological: Saline
Other: Physiotherapy + heel cap

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of our study is to determine whether one injection with plasma into the origin of the plantar fascia is an effective treatment of plantar fasciitis.

90 patients will be randomized into three groups. 30 patients will be treated with one plasma injection, 30 patients will be treated with one injection with saline and 30 patients will do physiotherapy and use heel cups. The two groups who receive injections will do the same physiotherapy and use heel cups, as the conservatively treated group.

Both groups randomized to receive an injection will have a 10 ml blood sample taken from their cubital vein. The sample is centrifuged for 5 minutes at 5000 rpm. No additives are added. 3 ml of plasma i obtained, and the syringe i blinded. Is the patient randomized to receive an injection with saline, a similar syringe is blinded with 3 ml of saline. The injection into to the origin of the plantar fascia i done 10 minutes after the sample of blood is obtained. The content of the syringe i blinded to both the investigator and the patient.

The injection i performed from the medial aspect of the heel under guidance of ultrasound. No local/systemic analgetic is used. The content of the syringe is spread using peppering technique into the origin of the plantar fascia.

Patients will do questionnaires at inclusion and after 1, 2, 3, 6 and 12 months. The questionaires will be Foot Function Index and SF-36 as well as questions about their use of analgetics, use of heel cups and intensity of their physiotherapy

Enrollment

90 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • between 18 and 70 of age
  • Sore at the insertion of the plantar fascia on calcaneus
  • A VAS score of at least 4 at the insertion of the plantar fascia on calcaneus taking the first step in the morning
  • Symptoms for 6 to 12 months
  • Ability to understand danish and give informed consent

Exclusion criteria

  • Previously operated in the same ankle or foot
  • Pain anywhere else in the foot on palpation otherwise than at the insertion of the plantar fascia on calcaneus
  • Inflammatory disease
  • Diabetes
  • Formerly rupture of the Achilles tendon
  • Formerly treated with plasma injections
  • Ongoing infection treated with antibiotics
  • Treated with steroid during the trial
  • Treatment of the plantar fasciitis exceeding conservative treatment
  • Use of crutches, walker or similar
  • Pregnancy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

90 participants in 3 patient groups

Plasma
Experimental group
Treatment:
Biological: Plasma
Saline
Sham Comparator group
Treatment:
Biological: Saline
Physiotherapy + heel cap
Active Comparator group
Treatment:
Other: Physiotherapy + heel cap

Trial contacts and locations

1

Loading...

Central trial contact

Bjørn Nedergaard, Cand. Med.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems